Michael Mokotoff

630 total citations
39 papers, 489 citations indexed

About

Michael Mokotoff is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Michael Mokotoff has authored 39 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in Michael Mokotoff's work include Chemical Synthesis and Analysis (12 papers), Peptidase Inhibition and Analysis (9 papers) and Neuropeptides and Animal Physiology (5 papers). Michael Mokotoff is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Peptidase Inhibition and Analysis (9 papers) and Neuropeptides and Animal Physiology (5 papers). Michael Mokotoff collaborates with scholars based in United States, Israel and China. Michael Mokotoff's co-authors include Jiehua Zhou, Edward D. Ball, S. Morris Kupchan, Donald J. Abraham, Ming Zhao, Leonard D. Shultz, Arthur E. Jacobson, Abraham Patchornik, L E Hokin and Xing Yuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Michael Mokotoff

39 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Mokotoff United States 14 289 131 113 71 54 39 489
Deborah Rothman United States 15 331 1.1× 133 1.0× 42 0.4× 61 0.9× 29 0.5× 19 614
Gene K. Yee United States 8 383 1.3× 76 0.6× 171 1.5× 22 0.3× 44 0.8× 12 706
Hye-Ja Oh United States 13 471 1.6× 118 0.9× 176 1.6× 85 1.2× 15 0.3× 19 662
Giang T. Le Australia 14 537 1.9× 249 1.9× 108 1.0× 60 0.8× 25 0.5× 18 825
Moshe Weitzberg United States 15 242 0.8× 266 2.0× 62 0.5× 14 0.2× 24 0.4× 28 638
Matthew G. Bursavich United States 17 504 1.7× 379 2.9× 106 0.9× 39 0.5× 25 0.5× 29 904
Kokichi Suzuki Japan 10 144 0.5× 115 0.9× 86 0.8× 23 0.3× 12 0.2× 15 399
Jag Heer United Kingdom 12 343 1.2× 269 2.1× 94 0.8× 44 0.6× 18 0.3× 21 681
Klaus Urbahns Germany 15 283 1.0× 173 1.3× 192 1.7× 61 0.9× 30 0.6× 27 683
Kevin R. Kupcho United States 10 481 1.7× 80 0.6× 104 0.9× 20 0.3× 46 0.9× 22 707

Countries citing papers authored by Michael Mokotoff

Since Specialization
Citations

This map shows the geographic impact of Michael Mokotoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mokotoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mokotoff more than expected).

Fields of papers citing papers by Michael Mokotoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mokotoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mokotoff. The network helps show where Michael Mokotoff may publish in the future.

Co-authorship network of co-authors of Michael Mokotoff

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Mokotoff. A scholar is included among the top collaborators of Michael Mokotoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Mokotoff. Michael Mokotoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jiehua, Jian Chen, Michael Mokotoff, & Edward D. Ball. (2004). Targeting gastrin-releasing peptide receptors for cancer treatment. Anti-Cancer Drugs. 15(10). 921–927. 29 indexed citations
3.
Zhao, Ming, Hynda K. Kleinman, & Michael Mokotoff. (1997). Synthesis and activity of partial retro‐inverso analogs of the antimetastatic laminin‐derived peptide, YIGSR‐NH2. Journal of Peptide Research. 49(3). 240–253. 9 indexed citations
4.
Mokotoff, Michael, et al.. (1997). Evaluation of laminin peptide fragments labeled with indium‐111 for the potential imaging of malignant tumors. Journal of Peptide Research. 49(6). 510–516. 8 indexed citations
5.
Mokotoff, Michael, Jian Chen, Jiehua Zhou, & Edward D. Ball. (1996). Targeting Growth Factor Receptors with Bispecific Molecules. Current Medicinal Chemistry. 3(2). 87–100. 6 indexed citations
7.
Zhao, Ming, et al.. (1994). Synthetic Laminin-like Peptides and Pseudopeptides as Potential Antimetastatic Agents. Journal of Medicinal Chemistry. 37(20). 3383–3388. 14 indexed citations
8.
Mokotoff, Michael, et al.. (1992). Synthesis and biological evaluation of novel potent antagonists of the bombesin/gastrin releasing peptide receptor. Journal of Medicinal Chemistry. 35(25). 4696–4703. 5 indexed citations
9.
Mokotoff, Michael, et al.. (1992). Direct effect of bombesin on pancreatic and gastric growth in suckling rats. Regulatory Peptides. 41(2). 157–169. 6 indexed citations
10.
Brooks, Charles L., et al.. (1991). A CHARMM analysis of the conformations of the metastasis-inhibiting laminin pentapeptide. Journal of Protein Chemistry. 10(3). 265–271. 20 indexed citations
11.
Mokotoff, Michael, et al.. (1990). Peptidyl aminosteroids as potential new antiarrhythmic agents. Steroids. 55(9). 399–404. 11 indexed citations
12.
Mokotoff, Michael, et al.. (1990). Thymosin-like peptides as potential immunostimulants. Synthesis via the polymeric-reagent method. Journal of Medicinal Chemistry. 33(1). 354–360. 16 indexed citations
13.
Mokotoff, Michael, et al.. (1987). Design, synthesis, and testing of potential antisickling agents. 9. Cyclic tetrapeptide homologs as mimics of the mutation site of hemoglobin S. International journal of peptide & protein research. 29(4). 509–520. 8 indexed citations
14.
Mokotoff, Michael, et al.. (1984). Chlorine migration in the mass spectra of tert-butyldimethylsilyl derivatives of chloro alcohols. The Journal of Organic Chemistry. 49(8). 1441–1442. 11 indexed citations
15.
Mokotoff, Michael & Abraham Patchornik. (1983). Synthesis of the C‐terminal half of thymosin α1 by the polymeric reagent method. International journal of peptide & protein research. 21(2). 145–154. 15 indexed citations
16.
Mokotoff, Michael, et al.. (1977). Azabicyclo chemistry. 6. An investigation of one of the chemical parameters for analgetic activity. Synthesis of 2-methyl-2-azabicyclo[3.3.1]non-6-ene and -non-7-ene. Journal of Medicinal Chemistry. 20(11). 1493–1496. 5 indexed citations
17.
Mokotoff, Michael, et al.. (1975). Potential inhibitors of L-asparagine biosynthesis. 2. Chemistry and biological activity of .beta.-hydroxyaspartic acid and its derivatives. Journal of Medicinal Chemistry. 18(4). 354–358. 4 indexed citations
18.
Mokotoff, Michael, et al.. (1975). Potential inhibitors of L-asparagine biosynthesis. 3. Aromatic sulfonyl fluoride analogs of L-asparagine and L-glutamine. Journal of Medicinal Chemistry. 18(9). 888–891. 3 indexed citations
19.
Mokotoff, Michael. (1973). Azabieyclo chemistry III. Reduction and concomitant hydrogenolysis of 1‐Methyl‐7‐methoxyindole. Stereochemical assignments. Journal of Heterocyclic Chemistry. 10(6). 1063–1065. 5 indexed citations
20.
Mokotoff, Michael, et al.. (1972). Potential inhibitors of L-asparagine biosynthesis. I. .beta.-Elimination reactions with .beta.-hydroxyaspartic acid derivatives. The Journal of Organic Chemistry. 37(17). 2786–2788. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026